Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| 乳房腫瘍摘出術 | から $12,510 | から $2,700 | から $8,500 |
| 乳房切除術 | から $12,510 | から $4,500 | から $10,000 |
| 乳房再建術 | から $14,200 | から $3,936 | から $12,000 |
| 乳がん手術 | から $12,500 | から $6,010 | から $15,000 |
ソウラスキー医療センターにて41年の経験以上にわたり乳癌を専門とするメリムスキー博士は、腫瘍内科学の准教授および元科長です。
Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.
Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.
Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.
Seeing a breast cancer specialist in Israel provides research-driven care focused on niche conditions like lobular carcinoma. Specialists like Professor Tamar Jablonski-Perec at Hadassah lead dedicated clinics. They use targeted therapies like Keytruda and personalized methods that generalists may not perform daily.
Bookimed Expert Insight: Choosing a specialist who heads a department, like Dr. Beatrice Uziely at Hadassah, provides access to a wealth of research. These leaders often manage dozens of clinical grants and have published 50+ studies. This ensures your treatment plan includes the latest global findings and not just standard local protocols.
Patient Consensus: Patients notice that breast cancer specialists feel more dialed in to small nuances than generalists. One person felt much more confident after a specialist explained tailored options in plain language. Many suggest asking how many specific breast cases a doctor handles annually before starting treatment.
Israel offers high 5-year survival rates of around 90 percent and rapid access to innovative immunotherapies. Board-certified specialists like Dr. Sonnenblick Amir and Dr. Ofer Merimsky provide research-backed personalized care. Facilities like Sourasky and Assuta utilize advanced genomic profiling and breast-preserving surgical techniques.
Bookimed Expert Insight: Patients benefit from rare dual-specialization patterns in Israel – such as Dr. Tamar Sapra who is licensed in both oncological gynecology and radiotherapy. This allows one doctor to manage integrated treatment plans – reducing communication gaps between different medical departments during complex care.
Patient Consensus: Patients were impressed by how quickly blood tests and diagnostics were completed. They noticed the hospitals use very new equipment – which made them feel the higher costs were justified.
Israel offers many English-speaking breast cancer specialists, including Dr. Oscar Aballay at Sourasky Medical Center. Many top oncologists trained or completed fellowships in the US – like Dr. Sonnenblick Amir at Emory University and Professor Tamar Jablonski-Perec at Sloan-Kettering – so they communicate fluently with international patients.
Bookimed Expert Insight: A major advantage in Israel is access to specialists who lead national genomic medicine initiatives. For example, Dr. Ari Raphael at Sourasky Medical Center integrates liquid biopsies and genomic profiling. This allows doctors to tailor immunotherapy trials specifically to a patient's unique genetic tumor markers.
Patient Consensus: Patients are often relieved that doctors explain every step of the testing process in clear English. One person noted that having a specialist who spent years training in New York made navigating the complex treatment plan much easier.
Breast surgeons in Israel recommend oncoplastic surgery to combine cancer removal with immediate reconstruction. Specialists use these methods to preserve breast appearance without compromising the oncology treatment. Many surgeons hold certifications from the European Commission for Certification in Oncosurgery or have trained at top US centers like MD Anderson.
Bookimed Expert Insight: Patients can access doctors with highly specific clinical focuses within breast surgery. For instance, Dr. Ofer Merimsky at Sourasky has over 25+ years of experience that includes a doctoral thesis solely on lobular carcinoma in situ. This deep research-based specialization often leads to more tailored surgical planning compared to general oncology care.
Patient Consensus: Patients often mention their relief at how detailed surgeons are about the final aesthetic result during early discussions. Many noted that having reconstruction options explained before the first surgery made the recovery process feel much more manageable.
Israel offers advanced genetic counseling for breast cancer through national genomic initiatives and specialized centers. Experts like Dr. Ari Raphael at Sourasky Medical Center lead national programs focused on genomic profiling and liquid biopsies to identify hereditary risks and guide personalized therapy.
Bookimed Expert Insight: Israeli genetic counseling stands out because it is directly led by top-tier oncologists rather than general counselors. For example, Dr. Ari Raphael at Sourasky Medical Center leads a national genomic medicine initiative, while Dr. Liron Eldor at Rambam specifically researches genetic causes to improve surgical outcomes. This means your genetic profile is interpreted by the same specialists who design your biological or surgical treatment plan.
Patient Consensus: Patients often mention their doctors provided clear explanations about why certain genetic tests were needed. They felt relieved when specialists used these genetic results to choose targeted therapies that were more effective for their specific cancer type.